posit
predict
valu
influenzalik
ill
criteria
adult
transplant
patient
case
multiplex
respiratori
viru
pcr
test
abstract
background
respiratori
viral
infect
rvi
signific
caus
morbid
mortal
among
transplant
patient
cdc
influenzalik
ill
ili
criteria
fever
cough
andor
sore
throat
screen
tool
influenza
unknown
applic
transplant
popul
method
review
respiratori
viru
pcr
test
perform
adult
patient
histori
solid
organ
sot
stem
cell
transplant
hsct
influenza
season
posit
ppv
neg
predict
valu
npv
ili
criteria
calcul
result
transplant
patient
hsct
sot
test
posit
rvi
pcr
influenza
noninfluenza
patient
met
ili
criteria
posit
influenza
ppv
npv
ili
influenza
respect
mortal
low
morbid
high
requir
icu
stay
among
transplant
patient
diagnos
rvi
conclus
influenza
noninfluenza
rvi
associ
signific
morbid
among
transplant
patient
cdc
ili
criteria
correl
poorli
pcrposit
case
influenza
transplant
patient
may
use
exclud
diagnosi
routin
rvi
pcr
test
recommend
better
diagnosi
improv
antivir
use
transplant
patient
suspect
rvi
respiratori
viral
infect
rvi
particularli
influenza
parainfluenza
adenoviru
respiratori
syncyti
viru
rsv
common
caus
upper
lower
respiratori
tract
infect
among
patient
histori
solid
organ
transplant
sot
hematopoiet
stem
cell
transplant
hsct
rvi
associ
increas
morbid
mortal
transplant
popul
influenzaassoci
mortal
particular
may
approach
among
hsct
recipi
sot
recipi
addit
rvi
associ
numer
infecti
complic
secondari
bacteri
pneumonia
report
sot
recipi
influenza
allograft
dysfunct
acut
reject
addit
seriou
noninfecti
sequela
rvi
among
transplant
patient
accur
distinguish
influenza
respiratori
infect
great
interest
given
avail
effect
influenza
treatment
prompt
initi
antivir
therapi
among
patient
confirm
influenza
shown
reduc
durat
ill
mortal
date
limit
therapeut
option
rvi
treatment
remain
support
nonetheless
time
diagnosi
noninfluenza
rvi
benefici
facilit
implement
appropri
infect
control
measur
therebi
limit
persontoperson
transmiss
reduc
unnecessari
antibioticantivir
exposur
center
diseas
control
prevent
cdc
establish
influenzalik
ill
ili
criteria
identifi
patient
possibl
influenza
criteria
includ
fever
either
cough
sore
throat
criteria
intend
use
primarili
epidemiolog
tool
frequent
util
screen
tool
clinic
decisionmak
set
influenza
epidem
criteria
perform
well
among
gener
popul
presenc
cough
fever
posit
predict
valu
diagnosi
influenza
among
outpati
adult
children
transplant
recipi
frequent
atyp
manifest
influenza
includ
absenc
fever
therefor
applic
cdc
ili
criteria
popul
uncertain
studi
retrospect
character
respiratori
viru
infect
observ
among
solid
organ
bone
marrow
transplant
recipi
use
multipl
respiratori
viru
revers
transcriptas
polymeras
chain
reaction
pcr
evalu
perform
cdc
ili
criteria
popul
studi
approv
institut
review
board
rush
univers
medic
center
tertiari
academ
center
chicago
patient
underw
respiratori
viral
pcr
test
decemb
februari
retrospect
identifi
studi
period
repres
peak
influenza
season
posit
rate
rvi
among
patient
test
respiratori
viru
test
perform
use
luminex
xtag
respiratori
viral
panel
austin
tx
usa
qualit
multiplex
pcr
use
detect
differ
virus
subtyp
includ
respiratori
syncyti
viru
rsv
b
influenza
includ
subtyp
influenza
b
parainfluenza
virus
coronavirus
human
metapneumoviru
hmpv
adenoviru
rhinovirusenteroviru
specimen
submit
test
includ
nasopharyng
swab
sputum
bronchoalveolar
lavag
fluid
among
patient
underw
respiratori
viru
pcr
test
studi
period
adult
patient
yr
age
histori
transplant
hsct
sot
includ
analysi
incid
rvi
among
patient
determin
electron
medic
record
review
determin
whether
patient
fulfil
cdc
ili
criteria
fever
either
cough
sore
throat
sensit
specif
posit
neg
predict
valu
ili
criteria
laboratori
confirm
influenza
calcul
addit
inform
collect
medic
record
includ
patient
demograph
past
medic
surgic
histori
type
transplant
sign
symptom
time
test
prior
influenza
vaccin
immunosuppress
regimen
statist
analysi
perform
use
spss
softwar
version
chicago
il
usa
total
patient
underw
respiratori
viru
pcr
test
studi
period
patient
includ
analysi
reason
patient
exclus
includ
age
yr
patient
absenc
prior
transplant
patient
studi
patient
characterist
summar
tabl
transplant
patient
undergon
sot
histori
hsct
type
solid
organ
transplant
includ
kidney
liver
one
heart
hsct
patient
rel
equal
divid
allogen
autolog
transplant
sixtyseven
subject
male
averag
age
rang
yr
mean
time
transplant
test
rang
yr
thirtyon
patient
immunomodulatori
medic
time
test
corticosteroid
use
patient
without
addit
immunosuppress
medic
sixtythre
percent
patient
test
inpati
test
outpati
clinic
test
emerg
depart
fiftyfour
studi
patient
test
posit
respiratori
viru
commonli
isol
viru
influenza
case
influenza
two
influenza
b
thirti
patient
rvi
includ
rhinovirusenteroviru
rsv
coronaviru
parainfluenza
virus
hmpv
among
patient
influenza
receiv
influenza
season
vaccin
patient
start
empir
oseltamivir
patient
confirm
influenza
b
use
pcr
test
patient
one
type
respiratori
viru
detect
bacteri
superinfect
rare
report
one
patient
parainfluenza
infect
develop
secondari
streptococcu
pneumonia
bacteri
pneumonia
seven
transplant
patient
test
rvi
via
bronchoalveolar
lavag
specimen
among
patient
test
addit
respiratori
opportunist
infect
includ
cytomegaloviru
pneumocysti
jirovecii
perform
none
detect
twelv
patient
noninfluenza
rvi
requir
hospit
requir
icu
stay
compar
two
influenza
posit
patient
requir
icu
level
care
p
fisher
exact
test
mean
length
stay
patient
hospit
noninfluenza
rvi
significantli
longer
compar
patient
influenza
p
three
death
among
studi
patient
overal
mortal
three
patient
die
studi
period
two
test
posit
rvi
one
influenza
rhinovirusenteroviru
among
studi
patient
cough
frequent
report
symptom
occur
patient
nearli
onethird
patient
measur
fever
temperatur
time
test
subject
fever
present
slightli
often
patient
test
patient
report
sore
throat
tabl
patient
met
cdc
ili
criteria
pcrconfirm
influenza
seven
patient
fulfil
ili
criteria
noninfluenza
respiratori
viru
isol
remain
patient
respiratori
viru
detect
sensit
cdc
ili
criteria
identif
patient
influenza
confid
interv
ci
specif
ci
posit
predict
valu
ppv
ili
influenza
ci
neg
predict
valu
npv
ci
subgroup
analys
patient
immunosuppress
medic
includ
corticosteroid
patient
histori
hsct
patient
histori
sot
reveal
similar
perform
ili
criteria
across
group
tabl
among
particip
symptom
predict
influenza
rvi
cough
lr
p
temperatur
lr
p
symptom
predict
noninfluenza
rvi
rhinorrhea
lr
p
result
studi
reveal
clinic
present
specif
respiratori
virus
larg
indistinguish
one
anoth
specif
found
cdc
ili
criteria
reliabl
identifi
transplant
recipi
influenza
ppv
low
ppv
result
overus
oseltamivir
failur
consid
noninfluenza
rvi
interestingli
found
npv
ili
criteria
confirm
influenza
rel
high
presenc
rhinorrhea
found
predict
noninfluenza
rvi
combin
rhinorrhea
failur
meet
ili
criteria
may
use
identifi
transplant
patient
noninfluenza
rvi
howev
sign
symptom
influenza
noninfluenza
virus
overlap
greatli
unrealist
expect
clinician
distinguish
clinic
even
peak
influenza
season
past
ili
criteria
use
rapidli
triag
patient
possibl
influenza
await
result
viral
cultur
could
take
although
prolong
turnaround
time
tradit
viral
cultur
techniqu
routin
allow
identif
virus
influenza
includ
rsv
parainfluenza
adenoviru
howev
avail
rapid
molecular
diagnost
util
ili
criteria
diminish
multiplex
respiratori
viru
pcr
test
abil
rapid
accur
test
numer
respiratori
virus
therefor
larg
replac
viral
cultur
diagnost
gold
standard
multiplex
respiratori
viru
pcr
provid
discrimin
mani
respiratori
viral
pathogen
high
level
specif
sensit
includ
determin
specif
influenza
subtyp
unfortun
barrier
widespread
implement
multiplex
pcr
test
test
moder
highli
complex
assay
preclud
nearpati
test
also
increas
cost
associ
pcr
test
therefor
simpl
rapid
antigen
pointofcar
test
poor
sensit
singl
target
ie
influenza
frequent
use
outpati
set
larg
portion
rvi
test
occur
studi
howev
inpati
set
increas
cost
multiplex
pcr
test
offset
reduct
hospit
length
stay
associ
sensit
rapid
molecular
diagnost
importantli
identifi
specif
noninfluenza
pathogen
import
treatment
prognost
implic
studi
noninfluenza
virus
whole
n
common
caus
rvi
influenza
n
addit
known
benefit
prompt
administr
antivir
therapi
patient
influenza
data
suggest
potenti
role
use
system
inhal
ribavirin
treatment
rsv
infect
among
adult
hsct
recipi
studi
experiment
agent
treatment
rvi
also
ongo
identif
noninfluenza
rvi
may
allow
discontinu
unnecessari
oseltamivir
antibacteri
therapi
regard
prognosi
recent
data
campbel
et
al
show
infect
respiratori
viru
preallogen
hsct
includ
rhinoviru
associ
lower
surviv
mortal
low
transplant
cohort
may
due
long
median
durat
time
transplant
median
yr
rang
yr
mortal
secondari
infect
greatest
highli
immunosuppress
earli
posttranspl
period
also
found
low
incid
bacteri
superinfect
may
repres
underestim
due
failur
microbiolog
confirm
secondari
bacteri
pneumonia
howev
signific
morbid
associ
noninfluenza
rvi
among
transplant
recipi
assess
length
hospit
need
icu
level
care
addit
bacteri
superinfect
among
cohort
occur
patient
noninfluenza
rvi
overal
patient
test
vaccin
influenza
among
transplant
patient
test
posit
influenza
nearli
onethird
receiv
influenza
vaccin
earlier
season
signific
differ
incid
vaccin
failur
hsct
patient
sot
patient
p
one
vaccin
hsct
patient
diagnos
influenza
requir
icu
admiss
expir
inactiv
influenza
vaccin
safe
immunocompromis
patient
transplant
recipi
encourag
receiv
annual
influenza
vaccin
vaccin
efficaci
within
gener
popul
vari
year
year
larg
depend
upon
degre
antigen
match
influenza
strain
vaccin
circul
commun
unfortun
even
set
good
match
vaccin
efficaci
may
reduc
among
transplant
recipi
particularli
earli
posttranspl
period
reduc
immunogen
vaccin
earli
posttranspl
period
influenza
vaccin
recommend
month
transplant
leav
patient
transplant
influenza
season
particularli
high
risk
find
highlight
import
good
infect
control
practic
vaccin
transplant
recipi
close
contact
prompt
diagnosi
treatment
influenza
transplant
recipi
regardless
vaccin
histori
studi
sever
limit
notabl
retrospect
design
result
inconsist
avail
data
regard
present
symptom
second
sampl
size
small
studi
perform
singl
tertiari
medic
center
addit
entir
influenza
season
captur
period
includ
studi
decemb
februari
repres
peak
influenza
season
period
high
influenza
preval
thought
ideal
time
test
accuraci
cdc
ili
criteria
pcrconfirm
influenza
howev
ppv
depend
preval
studi
may
overestim
ppv
ili
criteria
entir
durat
influenza
season
lastli
graft
dysfunct
graft
loss
reject
graftversushostdiseas
import
endpoint
transplant
popul
captur
retrospect
studi
nonetheless
describ
abl
identifi
marker
morbid
among
transplant
patient
rvi
best
knowledg
first
studi
evalu
perform
ili
criteria
transplant
popul
found
mani
virus
cocircul
influenza
indistinguish
clinic
present
ili
criteria
appear
predict
influenza
infect
among
transplant
patient
use
guid
clinic
decisionmak
given
signific
morbid
among
transplant
recipi
rvi
prompt
routin
multiplex
respiratori
viru
pcr
test
encourag
allow
accur
diagnosi
appropri
therapi
author
contribut
k
conceptu
design
studi
perform
literatur
search
assist
data
extract
perform
statist
analysi
review
revis
approv
final
manuscript
tabl
submit
h
conceptu
design
studi
perform
literatur
search
assist
data
collect
extract
review
revis
final
manuscript
tabl
submit
j
c
perform
literatur
search
perform
data
collect
extract
assist
statist
analysi
wrote
draft
manuscript
tabl
submit
